These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 902677)
1. The effect of an antacid on the bioavailability of indomethacin. Galeazzi RL Eur J Clin Pharmacol; 1977 Aug; 12(1):65-8. PubMed ID: 902677 [TBL] [Abstract][Full Text] [Related]
2. Effects of magnesium-aluminum hydroxide antacid on absorption of rufloxacin. Lazzaroni M; Imbimbo BP; Bargiggia S; Sangaletti O; Dal Bo L; Broccali G; Bianchi Porro G Antimicrob Agents Chemother; 1993 Oct; 37(10):2212-6. PubMed ID: 8257146 [TBL] [Abstract][Full Text] [Related]
3. Influence of an antacid containing aluminum and magnesium on the pharmacokinetics of cefixime. Healy DP; Sahai JV; Sterling LP; Racht EM Antimicrob Agents Chemother; 1989 Nov; 33(11):1994-7. PubMed ID: 2610509 [TBL] [Abstract][Full Text] [Related]
4. Effect of an aluminum- and magnesium-containing antacid on the bioavailability of garenoxacin in healthy volunteers. Krishna G; Kisicki JC; Olsen S; Grasela DM; Wang Z Pharmacotherapy; 2007 Jul; 27(7):963-9. PubMed ID: 17594201 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers. Stass H; Böttcher MF; Ochmann K Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441 [TBL] [Abstract][Full Text] [Related]
6. Oral bioavailability of nizatidine and ranitidine concurrently administered with antacid. Desager JP; Harvengt C J Int Med Res; 1989; 17(1):62-7. PubMed ID: 2565267 [TBL] [Abstract][Full Text] [Related]
7. High dose of antacid (Mylanta II) reduces bioavailability of ranitidine. Mihaly GW; Marino AT; Webster LK; Jones DB; Louis WJ; Smallwood RA Br Med J (Clin Res Ed); 1982 Oct; 285(6347):998-9. PubMed ID: 6289961 [TBL] [Abstract][Full Text] [Related]
8. Effects of magnesium-aluminum hydroxide and calcium carbonate antacids on bioavailability of ofloxacin. Flor S; Guay DR; Opsahl JA; Tack K; Matzke GR Antimicrob Agents Chemother; 1990 Dec; 34(12):2436-8. PubMed ID: 2088202 [TBL] [Abstract][Full Text] [Related]
9. Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin. Nix DE; Watson WA; Lener ME; Frost RW; Krol G; Goldstein H; Lettieri J; Schentag JJ Clin Pharmacol Ther; 1989 Dec; 46(6):700-5. PubMed ID: 2598571 [TBL] [Abstract][Full Text] [Related]
10. Effect of an antacid containing magnesium and aluminum on absorption, metabolism, and mechanism of renal elimination of pefloxacin in humans. Jaehde U; Sörgel F; Stephan U; Schunack W Antimicrob Agents Chemother; 1994 May; 38(5):1129-33. PubMed ID: 8067750 [TBL] [Abstract][Full Text] [Related]
11. Lack of effect of omeprazole or of an aluminium hydroxide/magnesium hydroxide antacid on the pharmacokinetics of lumiracoxib. Scott G; Vinluan Reynolds C; Milosavljev S; Langholff W; Shenouda M; Rordorf C Clin Pharmacokinet; 2004; 43(5):341-8. PubMed ID: 15080766 [TBL] [Abstract][Full Text] [Related]
12. Effects of Food and Antacids on Pharmacokinetics and Pharmacodynamics of Lesinurad, a Selective Urate Reabsorption Inhibitor. Shen Z; Lee CA; Valdez S; Yang X; Wilson DM; Flanagan T; Gillen M Clin Pharmacol Drug Dev; 2019 Jul; 8(5):647-656. PubMed ID: 30748125 [TBL] [Abstract][Full Text] [Related]
13. Influence of antacid and ranitidine on the pharmacokinetics of oral cefetamet pivoxil. Blouin RA; Kneer J; Ambros RJ; Stoeckel K Antimicrob Agents Chemother; 1990 Sep; 34(9):1744-8. PubMed ID: 1981000 [TBL] [Abstract][Full Text] [Related]
14. Lack of pharmacokinetic interaction between linezolid and antacid in healthy volunteers. Grunder G; Zysset-Aschmann Y; Vollenweider F; Maier T; Krähenbühl S; Drewe J Antimicrob Agents Chemother; 2006 Jan; 50(1):68-72. PubMed ID: 16377669 [TBL] [Abstract][Full Text] [Related]
15. Effect of antacids on the plasma concentration of phenoperidine. Calvey TN; Milne LA; Williams NE; Chan K; Murray GR Br J Anaesth; 1983 Jun; 55(6):535-9. PubMed ID: 6860522 [TBL] [Abstract][Full Text] [Related]
16. Effect of antacids on the bioavailability of diflunisal in the fasting and postprandial states. Tobert JA; DeSchepper P; Tjandramaga TB; Mullie A; Buntinx AP; Meisinger MA; Huber PB; Hall TL; Yeh KC Clin Pharmacol Ther; 1981 Sep; 30(3):385-9. PubMed ID: 7023791 [TBL] [Abstract][Full Text] [Related]
17. Radiotelemetric comparison of two antacids using the Heidelberg capsule. Gómez Puch LM; Ríos Solans G; Muñoz y Fernandez JR Arzneimittelforschung; 1984; 34(10A):1378-80. PubMed ID: 6548925 [TBL] [Abstract][Full Text] [Related]
18. Effect of antacid magaldrate oral suspension on in-vitro and in-vivo availability of indomethacin in dogs. al-Gohary OM; Hosny EA Pharm Acta Helv; 1997 Apr; 72(2):81-6. PubMed ID: 9112830 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of enoxacin absorption by antacids or ranitidine. Grasela TH; Schentag JJ; Sedman AJ; Wilton JH; Thomas DJ; Schultz RW; Lebsack ME; Kinkel AW Antimicrob Agents Chemother; 1989 May; 33(5):615-7. PubMed ID: 2751276 [TBL] [Abstract][Full Text] [Related]
20. Effect of an aluminium-hydroxide containing antacid on the oral bioavailability of pirenzepine. Vergin H; Herrlinger C; Gugler R Arzneimittelforschung; 1989 Apr; 39(4):520-3. PubMed ID: 2751741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]